Page 22 - Vistagen Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vistagen therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vistagen Therapeutics Today - Breaking & Trending Today

Why Is Pagaya Technologies (PGY) Stock Soaring 94% Today?

Pagaya Technologies (PGY) stock is rocketing higher on Friday despite a lack of news from the financial tech company today. ....

Pagaya Technologies , Vistagen Therapeutics , Intuitive Surgical , Penny Stocks , Low Volume Stocks ,

VistaGen Therapeutics (VTGN) Stock Plunges on Disappointing Clinical Data

VistaGen Therapeutics (VTGN) stock is falling hard on Friday after the company reported poor results from a Phase 3 study. ....

United States , Shawn Singh , Vistagen Therapeutics , Subjective Units , Distress Scale , Intuitive Surgical , American Express , Friday Stock Market ,

VistaGen Reports Topline Results from PALISADE-1 Phase 3 Clinical Trial for PH94B

VistaGen Reports Topline Results from PALISADE-1 Phase 3 Clinical Trial for PH94B
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.

Shawn Singh , Vistagen Therapeutics Inc , Vistagen Therapeutics , Chief Executive Officer ,

Baird Downgrades VistaGen Therapeutics (VTGN) to Neutral

Baird Downgrades VistaGen Therapeutics (VTGN) to Neutral
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Brian Skorney , Vistagen Therapeutics ,

VistaGen Therapeutics (VTGN) Set to Announce Quarterly Earnings on Thursday

VistaGen Therapeutics (NASDAQ:VTGN – Get Rating) is set to announce its earnings results after the market closes on Thursday, June 23rd. Analysts expect the company to announce earnings of ($0.06) per share for the quarter. VTGN stock opened at $0.99 on Monday. The stock has a market cap of $204.46 million, a PE ratio of […] ....

York Mellon Corp , Charles Schwab Investment Management Inc , Vistagen Therapeutics Inc , Renaissance Technologies , Blackrock Inc , Vistagen Therapeutics , Get Rating , Gen Therapeutics , Street Corp , New York Mellon Corp , Charles Schwab Investment Management , Schwab Investment Management , Nasdaq Vtgn ,